REFERENCEGoogle News, NIFTY/SENSEX·9d★ ON YOUR LIST
Dr Reddy's Stock Surges Over 2%; Outperforms Peers As Nifty Pharma Bucks Broader Weakness - NDTV ProfitStock · NSE
NIFTYPHARMA
Quote not available for NIFTYPHARMA. Yahoo Finance may not list this symbol with the .NS suffix; we'll move to a licensed feed in v2.
Positive
8
Neutral
13
Negative
4
News mentioning NIFTYPHARMA
Sentiment: +16%← All news
REFERENCEGoogle News, NIFTY/SENSEX·9d★ ON YOUR LIST
Nifty Pharma defies mkt slump, up 1% as select drugs exempt from US tariffs - Business StandardREFERENCEGoogle News, NIFTY/SENSEX·44d★ ON YOUR LIST
Sensex, Nifty end volatile session in green, Nifty Pharma and IT index shine, Indigo gains over 2% - India TV NewsVERIFIEDET Stocks·78d★ ON YOUR LIST
Pharma stocks slide as Trump's 100% generic drug tariff plan spooks investorsAI summary· NEGATIVE
- ·Indian drug shares declined on Wednesday following a US tariff announcement.
- ·The Nifty Pharma index saw a notable decrease, impacting companies with substantial US revenue.
- ·Analysts suggest focusing on domestically oriented Indian pharmaceutical firms.
VERIFIEDMint Markets·78d★ ON YOUR LIST
Top Gainers & Losers on 22 July: Bandhan Bank, PG Electroplast, Lupin, Delhivery, Voltas, IndiGo among top losersAI summary· NEGATIVE
- ·The Indian stock market experienced a sell-off on July 22, with the Nifty 50 closing 0.77% lower.
- ·Middle East tensions and concerns over US tariffs on pharmaceuticals contributed to the market decline.
- ·Broader markets fell over 1%, with Nifty Media and Nifty Pharma sectors seeing significant drops.
REFERENCEGoogle News, NIFTY/SENSEX·78d★ ON YOUR LIST
US tariff threat drags Nifty Pharma 1.4% lower; Lupin, Auropharma lead decline - BusinessLineREFERENCEGoogle News, NIFTY/SENSEX·78d★ ON YOUR LIST
Nifty Pharma Drops 2%; Sensex, Nifty Open Weak Amid Rising Crude Prices - outlookbusiness.comREFERENCEGoogle News, NIFTY/SENSEX·78d★ ON YOUR LIST
Gland Pharma, Lupin, Dr Reddy's: All Nifty Pharma Stocks In Red After Trump's Drug Tariff Plan - NDTV ProfitVERIFIEDMint Markets·78d★ ON YOUR LIST
Lupin, Sun Pharma to Cipla: Pharma stocks decline after Trump’s tariffs plan on generic medicines importAI summary· NEGATIVE
- ·Several Indian pharmaceutical companies experienced a decline in their stock prices.
- ·Aurobindo Pharma, Ajanta Pharma, Lupin, Gland Pharma, and Zydus Lifesciences were among the top decliners.
- ·The decline occurred following a plan by Donald Trump regarding tariffs on generic medicine imports.
REFERENCEGoogle News, NIFTY/SENSEX·78d★ ON YOUR LIST
Nifty Pharma crashes nearly 2%; Cipla, Dr Reddy's among top Nifty losers after Trump's tariff plan - Moneycontrol.comREFERENCEGoogle News, NIFTY/SENSEX·78d★ ON YOUR LIST
Nifty Pharma slides nearly 2%; Sun Pharma, Cipla, Dr Reddy's among top Nifty losers after Trump's tariff plan - TradingViewVERIFIEDMint Markets·80d★ ON YOUR LIST
Cipla, Ajanta Pharma to Alkem Laboratories: Pharma stocks rise amid weak trends on Dalal StreetAI summary· POSITIVE
- ·Torrent Pharmaceuticals and Mankind Pharma saw gains exceeding 3% on the Nifty Pharma index.
- ·Cipla, Divi’s Laboratories, Laurus Labs, Alkem Laboratories, and Sai Life Sciences shares increased by over 2%.
- ·The pharma stocks experienced a rise despite weak trends observed on the Dalal Street.
VERIFIEDMint Markets·85d★ ON YOUR LIST
Nifty Pharma jumps 14% YTD, outshines Nifty 50; is there more upside ahead?AI summary· POSITIVE
- ·The Nifty Pharma index has increased by 14.53% year-to-date.
- ·This performance surpasses the Nifty 50's decline of 7.87%.
- ·Improved earnings visibility and stable domestic formulation demand are key drivers for the pharma sector.
VERIFIEDMint Markets·86d★ ON YOUR LIST
Top Gainers & Losers on 14 July: HCL Tech, Ceat, Swiggy, Anant Raj, Newgen Software Tech among top losersAI summary· NEGATIVE
- ·Investor sentiment in India dipped on July 14, with the market experiencing losses exceeding 0.7%.
- ·Rising crude oil prices due to US-Iran tensions were a primary driver of the market downturn.
- ·Nifty Realty and PSU Bank indices were among the largest decliners, while Nifty Pharma showed positive performance.
REFERENCEGoogle News, NIFTY/SENSEX·101d★ ON YOUR LIST
Nifty Pharma Index Hits Fresh 52-Week High; Dr Reddy’s, Cipla, Ajanta Pharma Lead Rally on GLP-1 Opportunity - India InfolineREFERENCEGoogle News, NIFTY/SENSEX·107d★ ON YOUR LIST
Nifty Pharma jumps nearly 2%; Dr Reddy's, Sun Pharma and Cipla lead gains, dominate Nifty gainers list - Moneycontrol.comVERIFIEDMint Markets·122d★ ON YOUR LIST
Sun Pharma, Alkem Labs, other pharma stocks gain despite stock market crash; Nifty Pharma rises for fourth day in a rowAI summary· NEUTRAL
VERIFIEDEconomic Times News·136d★ ON YOUR LIST
Nifty Pharma, 4 others hit 52-week high since Iran war while Nifty fell 7%. Will the form continue?AI summary· POSITIVE
- ·Five Indian sectors, including Pharma, Energy, Defence, Capital Markets, and Metals, have reached 52-week highs.
- ·These sectors are demonstrating strength despite a challenging market influenced by geopolitical tensions and foreign fund outflows.
- ·The rise in these sectors is attributed to structural earnings visibility and long-term growth prospects.
VERIFIEDET Markets·136d★ ON YOUR LIST
Nifty Pharma, 4 others hit 52-week high since Iran war while Nifty fell 7%. Will the form continue?AI summary· POSITIVE
- ·Five Indian sectors, including Pharma, Energy, Defence, Capital Markets, and Metals, have reached 52-week highs.
- ·These sectors are demonstrating strength despite a challenging market influenced by geopolitical tensions and foreign fund outflows.
- ·The upward trend in these sectors is attributed to structural earnings visibility and long-term growth prospects.
VERIFIEDET Stocks·136d★ ON YOUR LIST
Nifty Pharma, 4 others hit 52-week high since Iran war while Nifty fell 7%. Will the form continue?AI summary· POSITIVE
- ·Five Indian sectors, including Pharma, Energy, Defence, Capital Markets, and Metals, have reached 52-week highs.
- ·This strength is observed despite a challenging market backdrop characterized by geopolitical tensions and foreign fund outflows.
- ·The sectors' performance is attributed to structural earnings visibility and long-term growth tailwinds.
VERIFIEDMint Markets·139d★ ON YOUR LIST
Top Gainers & losers on May 22: JSW Cement, Honasa Consumer, Tata Comm, Sammaan Capital, Trent among top gainersAI summary· NEUTRAL
VERIFIEDMint Markets·140d★ ON YOUR LIST
Gland Pharma to Biocon: Pharma stocks rally up to 27% in a month: Can they shield portfolio from US-Iran war-led risks?AI summary· POSITIVE
REFERENCEGoogle News, NIFTY/SENSEX·141d★ ON YOUR LIST
Mankind Pharma, Zydus Lifesciences fuel Nifty Pharma to 52-week high; index trades 9.8% higher YTD - UpstoxVERIFIEDET Markets·141d★ ON YOUR LIST
Mankind, other pharma stocks rally up to 7%; Nifty Pharma scales fresh peak. What lies ahead?AI summary· POSITIVE
- ·Pharma stocks rallied on Wednesday, with the Nifty Pharma index reaching a new 52-week high of 25,043.
- ·The Nifty Pharma index crossed the 25,000 mark, rebounding from early losses.
- ·The rally in pharma stocks was supported by strong earnings and a weakening rupee.
VERIFIEDMint Markets·147d★ ON YOUR LIST
Top Gainers & Losers on May 14: NLC India, Cipla, Bharti Airtel, Vedanta, MCX, BSE, Berger Paints among top gainersAI summary· POSITIVE
- ·Indian equities rebounded on May 14, with benchmark indices rising over 1%.
- ·The Nifty Pharma index surged 2.73%, while the Nifty IT index fell nearly 2%.
- ·The rupee hit a record low before recovering.